Neumora Therapeutics (NMRA) Prepaid Assets (2022 - 2026)

Neumora Therapeutics has reported Prepaid Assets for 5 years, with the latest figure at $6.4 million in Q1 2026.

• For the quarter ending Q1 2026, Prepaid Assets rose 47.95% year-over-year to $6.4 million; the trailing twelve-month figure through Mar 2026 stood at $6.4 million (up 47.95% YoY), and the FY2025 full-year result was $8.0 million, up 52.11% from the prior year.
• Prepaid Assets for Q1 2026 stood at $6.4 million, down from $8.0 million in the prior quarter.
• The five-year high for Prepaid Assets was $26.7 million in Q2 2024, with the low at $4.3 million in Q1 2025.
• Average Prepaid Assets over 5 years is $11.7 million, with a median of $7.2 million recorded in 2025.
• Year-over-year, Prepaid Assets surged 104.18% in 2023 and slumped 80.06% in 2025.
• Tracing NMRA's Prepaid Assets over 5 years: stood at $11.9 million in 2022, then soared by 104.18% to $24.3 million in 2023, then slumped by 78.33% to $5.3 million in 2024, then surged by 52.11% to $8.0 million in 2025, then slipped by 20.54% to $6.4 million in 2026.
• The last three Prepaid Assets figures came in at $6.4 million (Q1 2026), $8.0 million (Q4 2025), and $5.6 million (Q3 2025), per Business Quant data.

Peer Comparison